Advances in laboratory methods for detection and typing of norovirus

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 373-381

  Vinjé, Jan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME LINKED IMMUNOSORBENT ASSAY; FECES CULTURE; GENOME ANALYSIS; GENOTYPING TECHNIQUE; HUMAN; LABORATORY DIAGNOSIS; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MICROARRAY ANALYSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS DETECTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TYPING; CALICIVIRIDAE INFECTIONS; CLASSIFICATION; GASTROENTERITIS; IMMUNOASSAY; ISOLATION AND PURIFICATION; LABORATORY TEST; MOLECULAR DIAGNOSIS; PROCEDURES; SEROTYPING; UNITED STATES; VIROLOGY;

NOROVIRUS;

CALICIVIRIDAE INFECTIONS; CLINICAL LABORATORY TECHNIQUES; GASTROENTERITIS; GENOTYPING TECHNIQUES; HUMANS; IMMUNOASSAY; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR EPIDEMIOLOGY; NOROVIRUS; SEROTYPING; UNITED STATES;

EID: 84923053367     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01535-14     Document Type: Review

References (39)

1. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N Engl J Med 361:1776-1785. http://dx.doi.org/10.1056/NEJMra0804575.
2. Payne DC, Vinjé J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, Wikswo M, Shirley SH, Hall AJ, Lopman B, Parashar UD. 2013. Norovirus and medically attended gastroenteritisin U. S. children. N Engl J Med 368:1121-1130. http://dx.doi.org/10.1056/NEJMsa1206589.
3. Hall AJ, Wikswo ME, Manikonda K, Roberts VA, Yoder JS, Gould LH. 2013. Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States. Emerg Infect Dis 19:1305-1309. http://dx.doi.org/10.3201/eid1908.130482.
4. Hall AJ, Lopman BA, Payne DC, Patel MM, Gastañaduy PA, Vinjé J, Parashar UD. 2013. Norovirus disease in the United States. Emerg Infect Dis 19:1198-1205. http://dx.doi.org/10.3201/eid1908.130465.
5. Koo HL, Neill FH, Estes MK, Munoz FM, Cameron A, Dupont HL, Atmar RL. 2013. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J Pediatric Infect Dis Soc 2:57-60. http://dx.doi.org/10.1093/jpids/pis070.
6. Bok K, Green KY. 2012. Norovirus gastroenteritis in immunocompro-mised patients. N Engl J Med 367:2126-2132. http://dx.doi.org/10.1056/NEJMra1207742.
7. Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M, Blanchard TJ. 2010. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J Clin Virol 49:219-222. http://dx.doi.org/10.1016/j.jcv.2010.07.025.
8. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Ramani S, Hill H, Ferreira J, Graham DY. 2014. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis 209:1016-1022. http://dx.doi.org/10.1093/infdis/jit620.
9. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structureofthe Norwalk virus capsid. Science 286:287-290. http://dx.doi.org/10.1126/science.286.5438.287.
10. Vongpunsawad S, Venkataram Prasad BV, Estes MK. 2013. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J Virol 87:4818-4825. http://dx.doi.org/10.1128/JVI.03508-12.
11. Green K. 2013. Caliciviridae: the noroviruses, p 583-609. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Tse H, Lau SK, Chan WM, Choi GK, Woo PC, Yuen KY. 2012. Complete genome sequences of novel canine norovirusesinHong Kong. J Virol 86:9531-9532. http://dx.doi.org/10.1128/JVI.01312-12.
13. Kroneman A, Vega E, Vennema H, Vinjé J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 158:2059-2068. http://dx.doi.org/10.1007/s00705-013-1708-5.
14. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323. http://dx.doi.org/10.1016/j.virol.2005.11.015.
15. Martella V, Decaro N, Lorusso E, Radogna A, Moschidou P, Amorisco F, Lucente MS, Desario C, Mari V, Elia G, Banyai K, Carmichael LE, Buonavoglia C. 2009. Genetic heterogeneity and recombination in canine noroviruses. J Virol 83:11391-11396. http://dx.doi.org/10.1128/JVI.01385-09.
16. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. 2014. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol 52:147-155. http://dx.doi.org/10.1128/JCM.02680-13.
17. Siebenga JJ, Vennema H, Zheng DP, Vinjé J, Lee BE, Pang XL, Ho EC, Lim W, Choudekar A, Broor S, Halperin T, Rasool NB, Hewitt J, Greening GE, Jin M, Duan ZJ, Lucero Y, O'Ryan M, Hoehne M, Schreier E, Ratcliff RM, White PA, Iritani N, Reuter G, Koopmans M. 2009. Norovirus illness is a global problem: emergence and spread of no-rovirus GII. 4 variants, 2001-2007. J Infect Dis 200:802-812. http://dx.doi.org/10.1086/605127.
18. Leshem E, Wikswo M, Barclay L, Brandt E, Storm W, Salehi E, Desalvo T, Davis T, Saupe A, Dobbins G, Booth HA, Biggs C, Garman K, Woron AM, Parashar UD, Vinjé J, Hall AJ. 2013. Effects and clinical significance of GII. 4 Sydney norovirus, United States, 2012-2013. Emerg Infect Dis 19:1231-1238. http://dx.doi.org/10.3201/eid1908.130458.
19. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII. 4 antigenic variation. PLoS Pathog 8:e1002705. http://dx.doi.org/10.1371/journal.ppat.1002705.
20. Eden JS, Tanaka MM, Boni MF, Rawlinson WD, White PA. 2013. Recombination within the pandemic norovirus GII. 4 lineage. J Virol 87: 6270-6282. http://dx.doi.org/10.1128/JVI.03464-12.
21. Xi JN, Graham DY, Wang KN, Estes MK. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583. http://dx.doi.org/10.1126/science.2177224.
22. Ambert-Balay K, Pothier P. 2013. Evaluation of 4 immunochromato-graphic tests for rapid detectionofnorovirusinfaecal samples. JClin Virol 56:194-198. http://dx.doi.org/10.1016/j.jcv.2012.11.001.
23. Costantini V, Grenz L, Fritzinger A, Lewis D, Biggs C, Hale A, Vinjé J. 2010. Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol 48: 2770-2778. http://dx.doi.org/10.1128/JCM.00654-10.
24. Vennema H, de Bruin E, Koopmans M. 2002. Rational optimization of generic primers used for Norwalk-like virus detection by reverse trans-criptase polymerase chain reaction. J Clin Virol 25:233-235. http://dx.doi.org/10.1016/S1386-6532(02)00126-9.
25. Katayama K, Shirato-Horikoshi H, Kojima S, Kageyama T, Oka T, Hoshino F, Fukushi S, Shinohara M, Uchida K, Suzuki Y, Gojobori T, Takeda N. 2002. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology 299:225-239. http://dx.doi.org/10.1006/viro.2002.1568.
26. Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Takeda N, Katayama K. 2003. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 41:1548-1557. http://dx.doi.org/10.1128/JCM.41.4.1548-1557.2003.
27. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 17:1389-1395. http://dx.doi.org/10.3201/eid1708.101837.
28. Rolfe KJ, Parmar S, Mururi D, Wreghitt TG, Jalal H, Zhang H, Curran MD. 2007. An internally controlled, one-step, real-time RT-PCR assay for norovirus detection and genogrouping. JClin Virol 39:318-321. http://dx.doi.org/10.1016/j.jcv.2007.05.005.
29. Miura T, Parnaudeau S, Grodzki M, Okabe S, Atmar RL, Le Guyader FS. 2013. Environmental detection of genogroup I, II, and IV noroviruses by using a generic real-time reverse transcription-PCR assay. Appl Environ Microbiol 79:6585-6592. http://dx.doi.org/10.1128/AEM.02112-13.
30. Chan MC, Sung JJ, Lam RK, Chan PK, Lee NL, Lai RW, Leung WK. 2006. Fecal viral load and norovirus-associated gastroenteritis. Emerg Infect Dis 12:1278-1280. http://dx.doi.org/10.3201/eid1208.060081.
31. Phillips G, Lopman B, Tam CC, Iturriza-Gomara M, Brown D, Gray J. 2009. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis 9:63. http://dx.doi.org/10.1186/1471-2334-9-63.
32. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Pan-chalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acácio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiologyof diarrhoeal disease ininfants and young childrenin developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
33. Navidad JF, Griswold DJ, Gradus MS, Bhattacharyya S. 2013. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high-throughput, simultaneous detectionof bacteria, viruses, and parasites of clinical and public health importance. J Clin Microbiol 51:3018-3024. http://dx.doi.org/10.1128/JCM.00896-13.
34. Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM, Cunningham SA, Pritt BS, Patel R, Binnicker MJ. 2014. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol 52:3667-3673. http://dx.doi.org/10.1128/JCM.01637-14.
35. Kaplan JE, Gary GW, Baron RC, Singh N, Schonberger LB, Feldman R, Greenberg HB. 1982. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med 96:756-761.
36. Kroneman A, Vennema H, Deforche K, v d Avoort H, Peñaranda S, Oberste MS, Vinjé J, Koopmans M. 2011. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol 51:121-125. http://dx.doi.org/10.1016/j.jcv.2011.03.006.
37. Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, Hall AJ, Parashar UD, Leon JS, Lopman B. 2012. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 55:189-193. http://dx.doi.org/10.1093/cid/cis372.
38. Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, Lopman B. 2014. Infection control for norovirus. Clin Microbiol Infect 20:731-740. http://dx.doi.org/10.1111/1469-0691.12674.
39. Debbink K, Lindesmith LC, Baric RS. 2014. The state of norovirus vaccines. Clin Infect Dis 58:1746-1752. http://dx.doi.org/10.1093/cid/ciu120.